Peculiarities of the course of non-small cell lung cancer and the percentage / of lymphocytes in blood of patients considering gender specific difference, upon COVID-19 before the beginning of antitumor treatment

Peculiarities of the course of non-small cell lung cancer and the percentage / of lymphocytes in blood of patients considering gender specific difference, upon COVID-19 before the beginning of antitumor treatment

The issue of the peculiarities of the course of the malignant process and the informative value of hematological parameters in patients with non-small cell lung cancer (LC) considering gender specific difference, upon COVID-19 before the beginning of antitumor treatment, has been poorly studied.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:CARDIOMETRY 2024-11 (33), p.37-37
Hauptverfasser: Zhukova, G V, Frantsiyants, E M, Kharagezov, D A, Shikhlyarova, A I, Kaplieva, I V, Mirzoyan, E A, Milakin, A G, Zinkovich, M S
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The issue of the peculiarities of the course of the malignant process and the informative value of hematological parameters in patients with non-small cell lung cancer (LC) considering gender specific difference, upon COVID-19 before the beginning of antitumor treatment, has been poorly studied.
ISSN:2304-7232
DOI:10.18137/cardiometry.2024.33.conf.14